Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Colorectal Neoplasms

Free Subscription Articles published in PLoS One Retrieve available abstracts of 201 articles: HTML format

Single Articles

January 2023
1. PURNOMO HD, Permatadewi CO, Prasetyo A, Indiarso D, et al
   Colorectal cancer screening in Semarang, Indonesia: A multicenter primary health care based study.
   PLoS One. 2023;18:e0279570.
   PubMed     Abstract available
   
   
   
2. BEILMANN-LEHTONEN I, Kasurinen J, Hagstrom J, Kaprio T, et al
   High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
   PLoS One. 2023;18:e0280085.
   PubMed     Abstract available
   
   
   
3. NSO N, Nyabera A, Nassar M, Mbome Y, et al
   Incidence and risk factors of cardiovascular mortality in patients with gastrointestinal adenocarcinoma.
   PLoS One. 2023;18:e0262013.
   PubMed     Abstract available
   
   
   
4. SORENSEN AL, Guldmann-Christensen M, Borgesen M, Petersen RK, et al
   Detection of BRAF mutations in malignant melanoma and colorectal cancer by SensiScreen(R) FFPE BRAF qPCR assay.
   PLoS One. 2023;18:e0281558.
   PubMed     Abstract available
   
   
   
5. 
   Retraction: Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells.
   PLoS One. 2023;18:e0281614.
   PubMed    
   
   
   
6. CHOE L, Lau J, Yip LT, Kim G, et al
   Gastroscopy after positive screening for faecal immunochemical tests and colonoscopy: A systematic review.
   PLoS One. 2023;18:e0281557.
   PubMed     Abstract available
   
   
   
7. CHOI J, Kim N, Nam RH, Kim JW, et al
   Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis.
   PLoS One. 2023;18:e0282017.
   PubMed     Abstract available
   
   
   
8. GARCIA JA, Chen R, Xu M, Comerford SA, et al
   Acss2/HIF-2 signaling facilitates colon cancer growth and metastasis.
   PLoS One. 2023;18:e0282223.
   PubMed     Abstract available
   
   
   
9. VERNMARK K, Knutsen A, Loftas P, Sun XF, et al
   The impact of adjuvant chemotherapy on survival in mucinous and non-mucinous rectal adenocarcinoma patients after TME surgery.
   PLoS One. 2023;18:e0282211.
   PubMed     Abstract available
   
   
   
10. NISHIO M, Kunisaki R, Shibata W, Ajioka Y, et al
    Serrated polyps in patients with ulcerative colitis: Unique clinicopathological and biological characteristics.
    PLoS One. 2023;18:e0282204.
    PubMed     Abstract available
    
    
    
11. HU A, Roberts C, Moscalu A, Redston M, et al
    Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model.
    PLoS One. 2023;18:e0281529.
    PubMed     Abstract available
    
    
    
12. YANG X, Cao Q, Ma B, Xia Y, et al
    Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition.
    PLoS One. 2023;18:e0277155.
    PubMed     Abstract available
    
    
    
13. FAN F, Ghosh S, Powell R, Roszik J, et al
    Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.
    PLoS One. 2023;18:e0281063.
    PubMed     Abstract available
    
    
    
14. JEON J, Han EY, Jung I
    MOPA: An integrative multi-omics pathway analysis method for measuring omics activity.
    PLoS One. 2023;18:e0278272.
    PubMed     Abstract available
    
    
    
15. KIMLA LJ, Clark TG, Banerjee S, Campino S, et al
    JC Polyomavirus T-antigen protein expression and the risk of colorectal cancer: Systematic review and meta-analysis of case-control studies.
    PLoS One. 2023;18:e0283642.
    PubMed     Abstract available
    
    
    
16. TAKASAGO T, Hayashi R, Ueno Y, Ariyoshi M, et al
    Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model.
    PLoS One. 2023;18:e0283822.
    PubMed     Abstract available
    
    
    
17. YOKOYAMA S, Watanabe T, Fujita Y, Matsumura S, et al
    Histology of metastatic colorectal cancer in a lymph node.
    PLoS One. 2023;18:e0284536.
    PubMed     Abstract available
    
    
    
18. TANG Y, Guo H, Chen L, Wang X, et al
    Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases.
    PLoS One. 2023;18:e0284089.
    PubMed     Abstract available
    
    
    
19. TBEILEH N, Timmerman L, Mattis AN, Toriguchi K, et al
    Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
    PLoS One. 2023;18:e0271354.
    PubMed     Abstract available
    
    
    
20. JIN X, Cai C, Zhao J, Huang L, et al
    Opportunistic colonoscopy in healthy individuals: A non-trivial risk of adenoma.
    PLoS One. 2023;18:e0283575.
    PubMed     Abstract available
    
    
    
21. KAIDA T, Fujiyama Y, Soeno T, Yokota M, et al
    Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
    PLoS One. 2023;18:e0277395.
    PubMed     Abstract available
    
    
    
22. HUANG W, Ho CL, Lee CT, Chen WL, et al
    High concordance rate of capillary electrophoresis workflow for microsatellite instability analysis and mismatch repair (MMR) immunostaining in colorectal carcinoma.
    PLoS One. 2023;18:e0284227.
    PubMed     Abstract available
    
    
    
23. XU C, Zhang W, Liu C
    FAK downregulation suppresses stem-like properties and migration of human colorectal cancer cells.
    PLoS One. 2023;18:e0284871.
    PubMed     Abstract available
    
    
    
24. CHENG CT, Lai JM, Chang PM, Hong YR, et al
    Identifying essential genes in genome-scale metabolic models of consensus molecular subtypes of colorectal cancer.
    PLoS One. 2023;18:e0286032.
    PubMed     Abstract available
    
    
    
25. HAN CJ, Reding KW, Kalady MF, Yung R, et al
    Factors associated with long-term gastrointestinal symptoms in colorectal cancer survivors in the women's health initiatives (WHI study).
    PLoS One. 2023;18:e0286058.
    PubMed     Abstract available
    
    
    
26. RAYAN A, Soliman A
    Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery.
    PLoS One. 2023;18:e0285709.
    PubMed     Abstract available
    
    
    
27. PETAINEN L, Vayrynen JP, Ruusuvuori P, Polonen I, et al
    Domain-specific transfer learning in the automated scoring of tumor-stroma ratio from histopathological images of colorectal cancer.
    PLoS One. 2023;18:e0286270.
    PubMed     Abstract available
    
    
    
28. KIM J, Kim H, Yoon YS, Kim CW, et al
    Investigation of artificial intelligence integrated fluorescence endoscopy image analysis with indocyanine green for interpretation of precancerous lesions in colon cancer.
    PLoS One. 2023;18:e0286189.
    PubMed     Abstract available
    
    
    
29. XU Y, He L, Liu S, Zhang C, et al
    Intraoperative intravenous low-dose esketamine improves quality of early recovery after laparoscopic radical resection of colorectal cancer: A prospective, randomized controlled trial.
    PLoS One. 2023;18:e0286590.
    PubMed     Abstract available
    
    
    
30. TSAI KY, Wei PL, Azarkan M, M'Rabet N, et al
    Cytotoxic properties of unfractionated and fractionated bromelain alone or in combination with chemotherapeutic agents in colorectal cancer cells.
    PLoS One. 2023;18:e0285970.
    PubMed     Abstract available
    
    
    
31. TAHARA T, Takahama K, Tahara S, Horiguchi N, et al
    Endoscopic features of lymphoid follicles in the colonic mucosa using the image enhanced endoscopy and its association with colorectal adenoma.
    PLoS One. 2023;18:e0286300.
    PubMed     Abstract available
    
    
    
32. MORAITIS AM, Rose NB, Johnson AF, Dunston ER, et al
    Feasibility and acceptability of an mHealth, home-based exercise intervention in colorectal cancer survivors: A pilot randomized controlled trial.
    PLoS One. 2023;18:e0287152.
    PubMed     Abstract available
    
    
    
33. ZHENG W, Guo Y, Zhang G, Bai J, et al
    Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway.
    PLoS One. 2023;18:e0287133.
    PubMed     Abstract available
    
    
    
34. FRANZ C, Wuehrl M, Hartmann S, Klupp F, et al
    Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes.
    PLoS One. 2023;18:e0286486.
    PubMed     Abstract available
    
    
    
35. D'SOUZA J, Eglinton T, Frizelle F
    Readmission prediction after colorectal cancer surgery: A derivation and validation study.
    PLoS One. 2023;18:e0287811.
    PubMed     Abstract available
    
    
    
36. KWON MJ, Lee JY, Kim EJ, Ko EJ, et al
    Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels.
    PLoS One. 2023;18:e0287768.
    PubMed     Abstract available
    
    
    
37. CASTILHO MJC, Massago M, Arruda CE, Beltrame MHA, et al
    Spatial distribution of mortality from colorectal cancer in the southern region of Brazil.
    PLoS One. 2023;18:e0288241.
    PubMed     Abstract available
    
    
    
38. LEE WC, Digbeu BDE, Serag H, Sallam H, et al
    Utilization of diabetes self-management program among breast, prostate, and colorectal cancer survivors: Using 2006-2019 Texas Medicare data.
    PLoS One. 2023;18:e0289268.
    PubMed     Abstract available
    
    
    
39. CHERAGHI-SHAVI T, Jalal R, Minuchehr Z
    TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach.
    PLoS One. 2023;18:e0289535.
    PubMed     Abstract available
    
    
    
40. GEITENBEEK RTJ, Burghgraef TA, Broekman M, Schop BPA, et al
    Economic analysis of open versus laparoscopic versus robot-assisted versus transanal total mesorectal excision in rectal cancer patients: A systematic review.
    PLoS One. 2023;18:e0289090.
    PubMed     Abstract available
    
    
    
41. FATIMA SA, Nasim MT, Malik A, Rehman SU, et al
    In silico analysis and experimental validation shows negative correlation between miR-1183 and cell cycle progression gene 1 expression in colorectal cancer.
    PLoS One. 2023;18:e0289082.
    PubMed     Abstract available
    
    
    
42. PATRA R, Dey AK, Mukherjee S
    Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma.
    PLoS One. 2023;18:e0289064.
    PubMed     Abstract available
    
    
    
43. LIU Y, Du W, Guo Y, Tian Z, et al
    Identification of high-risk factors for recurrence of colon cancer following complete mesocolic excision: An 8-year retrospective study.
    PLoS One. 2023;18:e0289621.
    PubMed     Abstract available
    
    
    
44. OMAR A, Govan D, Penny C
    Epigenetic regulation in colorectal cancer: The susceptibility of microRNAs 145, 143 and 133b to DNA demethylation and histone deacetylase inhibitors.
    PLoS One. 2023;18:e0289800.
    PubMed     Abstract available
    
    
    
45. IMRAN M, Baig M, Alshuaibi RO, Almohammadi TA, et al
    Knowledge and awareness about colorectal cancer and barriers to its screening among a sample of general public in Saudi Arabia.
    PLoS One. 2023;18:e0290269.
    PubMed     Abstract available
    
    
    
46. DIEDRICH L, Brinkmann M, Dreier M, Rossol S, et al
    Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models.
    PLoS One. 2023;18:e0290353.
    PubMed     Abstract available
    
    
    
47. MUZI CD, Banegas MP, Guimaraes RM
    Colorectal cancer disparities in Latin America: Mortality trends 1990-2019 and a paradox association with human development.
    PLoS One. 2023;18:e0289675.
    PubMed     Abstract available
    
    
    
48. MAZUMDER H, Husain M, Hossain MF, Mahmud S, et al
    Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001-2018.
    PLoS One. 2023;18:e0290994.
    PubMed     Abstract available
    
    
    
49. MARTINEZ-MARIN D, Helmer RA, Kaur G, Washburn RL, et al
    Helicase-like transcription factor (HLTF)-deleted CDX/TME model of colorectal cancer increased transcription of oxidative phosphorylation genes and diverted glycolysis to boost S-glutathionylation in lymphatic intravascular metastatic niches.
    PLoS One. 2023;18:e0291023.
    PubMed     Abstract available
    
    
    
50. YAO D, He W, Hu Y, Yuan Y, et al
    Prevalence and influencing factors of probiotic usage among colorectal cancer patients in China: A national database study.
    PLoS One. 2023;18:e0291864.
    PubMed     Abstract available
    
    
    
51. SUTTON TS, Hao S, Suzuki M, Chua A, et al
    Rectal cancer presentation during the COVID-19 pandemic: Are decreasing screening rates leading to an increase in acute presentations?
    PLoS One. 2023;18:e0291447.
    PubMed     Abstract available
    
    
    
52. TESOLATO S, Ortega-Hernandez A, Gomez-Garre D, Claver P, et al
    Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.
    PLoS One. 2023;18:e0292551.
    PubMed     Abstract available
    
    
    
53. NINDRA U, Pal A, Lea V, Lim SH, et al
    Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population.
    PLoS One. 2023;18:e0292087.
    PubMed     Abstract available
    
    
    
54. BINGHAM SL, Small S, Semple CJ
    A qualitative evaluation of a multi-modal cancer prehabilitation programme for colorectal, head and neck and lung cancers patients.
    PLoS One. 2023;18:e0277589.
    PubMed     Abstract available
    
    
    
55. SAKOWITZ S, Bakhtiyar SS, Mallick S, Khoraminejad B, et al
    Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.
    PLoS One. 2023;18:e0293389.
    PubMed     Abstract available
    
    
    
56. WANG N, Shu L, Liu S, Yang L, et al
    Comparing endoscopic mucosal resection with endoscopic submucosal dissection in colorectal adenoma and tumors: Meta-analysis and system review.
    PLoS One. 2023;18:e0291916.
    PubMed     Abstract available
    
    
    
57. DASGUPTA P, Cameron JK, Goodwin B, Cramb SM, et al
    Geographical and spatial variations in bowel cancer screening participation, Australia, 2015-2020.
    PLoS One. 2023;18:e0288992.
    PubMed     Abstract available
    
    
    
58. KINDT IS, Martiny FHJ, Gram EG, Bie AKL, et al
    The risk of bleeding and perforation from sigmoidoscopy or colonoscopy in colorectal cancer screening: A systematic review and meta-analyses.
    PLoS One. 2023;18:e0292797.
    PubMed     Abstract available
    
    
    
59. IIZUKA D, Sasatani M, Ishikawa A, Daino K, et al
    Newly discovered genomic mutation patterns in radiation-induced small intestinal tumors of ApcMin/+ mice.
    PLoS One. 2023;18:e0292643.
    PubMed     Abstract available
    
    
    
60. AL-RAJAB M, Lu J, Xu Q, Kentour M, et al
    A hybrid machine learning feature selection model-HMLFSM to enhance gene classification applied to multiple colon cancers dataset.
    PLoS One. 2023;18:e0286791.
    PubMed     Abstract available
    
    
    
61. MALAGON M, Alwers E, Oliver L, Ramio-Pujol S, et al
    Clinical performance study of a fecal bacterial signature test for colorectal cancer screening.
    PLoS One. 2023;18:e0293678.
    PubMed     Abstract available
    
    
    
62. LEI Y, Lin L, Shao Q, Chen W, et al
    Long-term efficacy of transanal local excision versus total mesorectal excision after neoadjuvant treatment for rectal cancer: A meta-analysis.
    PLoS One. 2023;18:e0294510.
    PubMed     Abstract available
    
    
    
63. KOJIMAHARA N, Sato Y, Sato Y, Kojimahara F, et al
    Longitudinal analysis of long-term outcomes of colorectal cancer after laparotomy and laparoscopic surgery: The Shizuoka study.
    PLoS One. 2023;18:e0294589.
    PubMed     Abstract available
    
    
    
64. TAMURA S, Tazawa H, Hori N, Li Y, et al
    p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells.
    PLoS One. 2023;18:e0294491.
    PubMed     Abstract available
    
    
    
65. YANG M, Narasimhan VM, Zhan FB
    High polygenic risk score is a risk factor associated with colorectal cancer based on data from the UK Biobank.
    PLoS One. 2023;18:e0295155.
    PubMed     Abstract available
    
    
    January 2022
66. MEIJER TS, Dieters JHN, de Leede EM, de Geus-Oei LF, et al
    Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
    PLoS One. 2022;17:e0261939.
    PubMed     Abstract available
    
    
    
67. SHIRAISHI T, Tominaga T, Nonaka T, Hashimoto S, et al
    Effect of hemodialysis on short-term outcomes after colon cancer surgery.
    PLoS One. 2022;17:e0262531.
    PubMed     Abstract available
    
    
    
68. 
    Expression of Concern: Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-1beta- Dependent Stabilization of Snail in Tumor Cells.
    PLoS One. 2022;17:e0263429.
    PubMed    
    
    
    
69. DONG XF, Wang Y, Tang CH, Huang BF, et al
    Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation.
    PLoS One. 2022;17:e0263749.
    PubMed     Abstract available
    
    
    
70. ALAQBI SS, Burke L, Guterman I, Green C, et al
    Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells.
    PLoS One. 2022;17:e0262364.
    PubMed     Abstract available
    
    
    
71. VAN DER MEULEN MP, Toes-Zoutendijk E, Spaander MCW, Dekker E, et al
    Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.
    PLoS One. 2022;17:e0264067.
    PubMed     Abstract available
    
    
    
72. MITSAKOS AT, Irish W, Parikh AA, Snyder RA, et al
    The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer.
    PLoS One. 2022;17:e0263818.
    PubMed     Abstract available
    
    
    
73. MUTHAMILSELVAN S, Raghavendran A, Palaniappan A
    Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
    PLoS One. 2022;17:e0249151.
    PubMed     Abstract available
    
    
    
74. RYE MS, Garrett KL, Holt RA, Platell CF, et al
    Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
    PLoS One. 2022;17:e0262416.
    PubMed     Abstract available
    
    
    
75. MIYAKAWA T, Kawamura H, Honda M, Takano Y, et al
    Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study.
    PLoS One. 2022;17:e0264652.
    PubMed     Abstract available
    
    
    
76. ILIC-ZIVOJINOVIC J, Krdzic I, Jovanovic A, Vukasinovic D, et al
    Transcultural adaptation and validation of the Serbian version of the colorectal-specific quality of life questionnaire FACT-C.
    PLoS One. 2022;17:e0263110.
    PubMed     Abstract available
    
    
    
77. DU J, Tao Q, Liu Y, Huang Z, et al
    Assessment of the targeted effect of Sijunzi decoction on the colorectal cancer microenvironment via the ESTIMATE algorithm.
    PLoS One. 2022;17:e0264720.
    PubMed     Abstract available
    
    
    
78. MEHRGOU A, Teimourian S
    Update of gene expression/methylation and MiRNA profiling in colorectal cancer; application in diagnosis, prognosis, and targeted therapy.
    PLoS One. 2022;17:e0265527.
    PubMed     Abstract available
    
    
    
79. MURAKAMI D, Matsuda K, Iwamoto H, Mitani Y, et al
    Prognostic value of CD155/TIGIT expression in patients with colorectal cancer.
    PLoS One. 2022;17:e0265908.
    PubMed     Abstract available
    
    
    
80. LEE KY, Lee J, Park YY, Oh ST, et al
    Use of gentamicin-collagen sponge (Collatamp(R) G) in minimally invasive colorectal cancer surgery: A propensity score-matched study.
    PLoS One. 2022;17:e0264513.
    PubMed     Abstract available
    
    
    
81. YANG WY, Izzi B, Bress AP, Thijs L, et al
    Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study.
    PLoS One. 2022;17:e0266481.
    PubMed     Abstract available
    
    
    
82. MENG F, Cao Y, Su H, Liu T, et al
    Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model.
    PLoS One. 2022;17:e0264896.
    PubMed     Abstract available
    
    
    
83. WONGKAEWKHIAW S, Wongrakpanich A, Krobthong S, Saengsawang W, et al
    Induction of apoptosis in human colorectal cancer cells by nanovesicles from fingerroot (Boesenbergia rotunda (L.) Mansf.).
    PLoS One. 2022;17:e0266044.
    PubMed     Abstract available
    
    
    
84. PELLAT A, Boutron I, Ravaud P
    Availability of results of interventional studies assessing colorectal cancer from 2013 to 2020.
    PLoS One. 2022;17:e0266496.
    PubMed     Abstract available
    
    
    
85. FILIPOWICZ N, Drezek K, Horbacz M, Wojdak A, et al
    Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.
    PLoS One. 2022;17:e0266111.
    PubMed     Abstract available
    
    
    
86. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    PubMed     Abstract available
    
    
    
87. NEJADGHADERI SA, Roshani S, Mohammadi E, Yoosefi M, et al
    The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019.
    PLoS One. 2022;17:e0263403.
    PubMed     Abstract available
    
    
    
88. ZHANG H, Wang J, Yu T, Wang J, et al
    Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK.
    PLoS One. 2022;17:e0265901.
    PubMed     Abstract available
    
    
    
89. LOPEZ-JIMENEZ T, Duarte-Salles T, Plana-Ripoll O, Recalde M, et al
    Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
    PLoS One. 2022;17:e0264634.
    PubMed     Abstract available
    
    
    
90. ISIK Z, Leblebici A, Demir Karaman E, Karaca C, et al
    In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps.
    PLoS One. 2022;17:e0267973.
    PubMed     Abstract available
    
    
    
91. ZHANG Y, Liu X, Li A, Tang X, et al
    A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli.
    PLoS One. 2022;17:e0265655.
    PubMed     Abstract available
    
    
    
92. HUSSAN H, Zhao J, Badu-Tawiah AK, Stanich P, et al
    Utility of machine learning in developing a predictive model for early-age-onset colorectal neoplasia using electronic health records.
    PLoS One. 2022;17:e0265209.
    PubMed     Abstract available
    
    
    
93. KANG J, Kim H, Park H, Lee B, et al
    Risk factors and economic burden of postoperative anastomotic leakage related events in patients who underwent surgeries for colorectal cancer.
    PLoS One. 2022;17:e0267950.
    PubMed     Abstract available
    
    
    
94. GREENE MW, Abraham PT, Kuhlers PC, Lipke EA, et al
    Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis.
    PLoS One. 2022;17:e0268436.
    PubMed     Abstract available
    
    
    
95. KAUFMAN E, Williamson T, Mayrand MH, Burchell AN, et al
    Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV.
    PLoS One. 2022;17:e0268521.
    PubMed     Abstract available
    
    
    
96. OSHIMA K, Hirano H, Shoji H, Iwasa S, et al
    Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.
    PLoS One. 2022;17:e0269115.
    PubMed     Abstract available
    
    
    
97. LU F, Chen S, Shi W, Su X, et al
    GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-beta1/SMAD2 signaling pathway.
    PLoS One. 2022;17:e0269094.
    PubMed     Abstract available
    
    
    
98. AITCHISON A, Pearson JF, Purcell RV, Frizelle FA, et al
    Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia.
    PLoS One. 2022;17:e0269541.
    PubMed     Abstract available
    
    
    
99. MARTINEZ-LAGO N, Cameselle Garcia S, Alonso de Castro B, Gomez-Randulfe Rodriguez MI, et al
    Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
    PLoS One. 2022;17:e0269399.
    PubMed     Abstract available
    
    
    
100. LARABEE SM, Cheng K, Raufman JP, Hu S, et al
     Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.
     PLoS One. 2022;17:e0269618.
     PubMed     Abstract available
     
     
     
101. SOMUNCU B, Ekmekcioglu A, Antmen FM, Ertuzun T, et al
     Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.
     PLoS One. 2022;17:e0268391.
     PubMed     Abstract available
     
     
     
102. TYAGI A, Shabbir U, Chen X, Chelliah R, et al
     Phytochemical profiling and cellular antioxidant efficacy of different rice varieties in colorectal adenocarcinoma cells exposed to oxidative stress.
     PLoS One. 2022;17:e0269403.
     PubMed     Abstract available
     
     
     
103. CUNNINGHAM P, Sumal A, Patton E, Helms H, et al
     Ojeok-san ameliorates visceral and somatic nociception in a mouse model of colitis induced colorectal cancer.
     PLoS One. 2022;17:e0270338.
     PubMed     Abstract available
     
     
     
104. HAMABE A, Ishii M, Kamoda R, Sasuga S, et al
     Artificial intelligence-based technology for semi-automated segmentation of rectal cancer using high-resolution MRI.
     PLoS One. 2022;17:e0269931.
     PubMed     Abstract available
     
     
     
105. MARBUN VMG, Erlina L, Lalisang TJM
     Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer.
     PLoS One. 2022;17:e0267090.
     PubMed     Abstract available
     
     
     
106. FUNG PLP, Lau VNM, Ng FF, Leung WW, et al
     Perioperative changes in haemoglobin and ferritin concentrations from preoperative intravenous iron isomaltoside for iron deficiency anaemia in patients with colorectal cancer: A pilot randomised controlled trial.
     PLoS One. 2022;17:e0270640.
     PubMed     Abstract available
     
     
     
107. SRIPAN P, Pongnikorn D, Chitapanarux I, Tangmunkongvorakul A, et al
     Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: A population-based study.
     PLoS One. 2022;17:e0270670.
     PubMed     Abstract available
     
     
     
108. DE JONGE L, van de Schootbrugge-Vandermeer HJ, Breekveldt ECH, Spaander MCW, et al
     Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
     PLoS One. 2022;17:e0270223.
     PubMed     Abstract available
     
     
     
109. ZHU Y, Guo X, Zhang Q, Yang Y, et al
     Prognostic value of sarcopenia in patients with rectal cancer: A meta-analysis.
     PLoS One. 2022;17:e0270332.
     PubMed     Abstract available
     
     
     
110. CHEE CW, Zamakshshari NH, Lee VS, Abdullah I, et al
     Morindone from Morinda citrifolia as a potential antiproliferative agent against colorectal cancer cell lines.
     PLoS One. 2022;17:e0270970.
     PubMed     Abstract available
     
     
     
111. CUMMINGS A, Foster R, Calman L, Permyakova NV, et al
     Quality of life and health status in older adults (>/=65 years) up to five years following colorectal cancer treatment: Findings from the ColoREctal Wellbeing (CREW) cohort study.
     PLoS One. 2022;17:e0270033.
     PubMed     Abstract available
     
     
     
112. RIGTER LS, Snaebjornsson P, Rosenberg EH, Altena E, et al
     Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
     PLoS One. 2022;17:e0270591.
     PubMed     Abstract available
     
     
     
113. HANSEN TM, Nugent Z, Bernstein CN, Samadder NJ, et al
     Characteristics of colorectal cancer and use of colonoscopy before colorectal cancer diagnosis among individuals with inflammatory bowel disease: A population-based study.
     PLoS One. 2022;17:e0272158.
     PubMed     Abstract available
     
     
     
114. WANG D, Agrawal R, Zou S, Haseeb MA, et al
     Anatomic location of colorectal cancer presents a new paradigm for its prognosis in African American patients.
     PLoS One. 2022;17:e0271629.
     PubMed     Abstract available
     
     
     
115. AJAB S, Zoughbor S, Labania L, Olanda M, et al
     The role of microbiota in immunotherapy outcomes in colorectal cancer patients: A protocol for a systematic review.
     PLoS One. 2022;17:e0273314.
     PubMed     Abstract available
     
     
     
116. FEU S, Unzueta F, Ercilla A, Perez-Venteo A, et al
     RAD51 is a druggable target that sustains replication fork progression upon DNA replication stress.
     PLoS One. 2022;17:e0266645.
     PubMed     Abstract available
     
     
     
117. WU E, Ni J, Tao L, Xie T, et al
     A bidirectional Mendelian randomization study supports the causal effects of a high basal metabolic rate on colorectal cancer risk.
     PLoS One. 2022;17:e0273452.
     PubMed     Abstract available
     
     
     
118. LUND HAHEIM L, Thelle DS, Ronningen KS, Olsen I, et al
     Low level of antibodies to the oral bacterium Tannerella forsythia predicts bladder cancers and Treponema denticola predicts colon and bladder cancers: A prospective cohort study.
     PLoS One. 2022;17:e0272148.
     PubMed     Abstract available
     
     
     
119. OKAZAKI Y, Shibutani M, Nagahara H, Fukuoka T, et al
     Significance of information obtained during transanal drainage tube placement after anterior resection of colorectal cancer.
     PLoS One. 2022;17:e0271496.
     PubMed     Abstract available
     
     
     
120. OLSSON JB, Gugerel MB, Jessen SB, Jorgensen J, et al
     Colorectal cancer-associated SNP rs17042479 is involved in the regulation of NAF1 promoter activity.
     PLoS One. 2022;17:e0274033.
     PubMed     Abstract available
     
     
     
121. JANAKIRAMAN H, Becker SA, Bradshaw A, Rubinstein MP, et al
     Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model.
     PLoS One. 2022;17:e0273076.
     PubMed     Abstract available
     
     
     
122. CASTELO M, Sue-Chue-Lam C, Paszat L, Kishibe T, et al
     Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review.
     PLoS One. 2022;17:e0273396.
     PubMed     Abstract available
     
     
     
123. CHEONG C, Kang J, Min BS, Kim NK, et al
     Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors.
     PLoS One. 2022;17:e0270887.
     PubMed     Abstract available
     
     
     
124. LEE C, Kim S, Woo J
     A comparative analysis of factors influencing colorectal cancer's age standardized mortality ratio among Korean women in the hot and cold spots.
     PLoS One. 2022;17:e0273995.
     PubMed     Abstract available
     
     
     
125. LEE HW, Song B, Kim K
     Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation.
     PLoS One. 2022;17:e0273723.
     PubMed     Abstract available
     
     
     
126. GOFRIT ON, Gofrit B, Roditi Y, Popovtzer A, et al
     Patterns of metastases progression- The linear parallel ratio.
     PLoS One. 2022;17:e0274942.
     PubMed     Abstract available
     
     
     
127. PELOSI AC, Fernandes AMAP, Maciel LF, Silva AAR, et al
     Liquid chromatography coupled to high-resolution mass spectrometry metabolomics: A useful tool for investigating tumor secretome based on a three-dimensional co-culture model.
     PLoS One. 2022;17:e0274623.
     PubMed     Abstract available
     
     
     
128. JEONG JH, Yun JW, Kim HY, Heo CY, et al
     Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer.
     PLoS One. 2022;17:e0274555.
     PubMed     Abstract available
     
     
     
129. KAJIWARA SAITO M, Morishima T, Ma C, Koyama S, et al
     Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO).
     PLoS One. 2022;17:e0274918.
     PubMed     Abstract available
     
     
     
130. DAI L, Mugaanyi J, Zhang T, Tong J, et al
     A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas.
     PLoS One. 2022;17:e0274823.
     PubMed     Abstract available
     
     
     
131. WU J, Li Z, Zou J, Li L, et al
     A meta-analysis of the value of circulating tumor cells in monitoring postoperative recurrence and metastasis of colorectal cancer.
     PLoS One. 2022;17:e0274282.
     PubMed     Abstract available
     
     
     
132. NASCIMENTO AQ, Dantas DB, Melo GS, Gomes FC, et al
     Impact of sociodemographic factors and screening, diagnosis, and treatment strategies on colorectal cancer mortality in Brazil: A 20-year ecological study.
     PLoS One. 2022;17:e0274572.
     PubMed     Abstract available
     
     
     
133. DENIS V, Cassagnard N, Del Rio M, Cornillot E, et al
     Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells.
     PLoS One. 2022;17:e0274390.
     PubMed     Abstract available
     
     
     
134. 
     Correction: Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria.
     PLoS One. 2022;17:e0275512.
     PubMed     Abstract available
     
     
     
135. MESRI M, Hitchman L, Yiaesemidou M, Quyn A, et al
     Protocol: The role of defunctioning stoma prior to neoadjuvant therapy for locally advanced colonic and rectal cancer-A systematic review.
     PLoS One. 2022;17:e0275025.
     PubMed     Abstract available
     
     
     
136. WASSIE M, Beshah DT, Tiruneh YM
     Advanced stage presentation and its determinant factors among colorectal cancer patients in Amhara regional state Referral Hospitals, Northwest Ethiopia.
     PLoS One. 2022;17:e0273692.
     PubMed     Abstract available
     
     
     
137. ISHII M, Tominaga T, Nonaka T, Oyama S, et al
     Colon inflammatory index as a useful prognostic marker after R0 resection in patients with colorectal cancer liver metastasis.
     PLoS One. 2022;17:e0273167.
     PubMed     Abstract available
     
     
     
138. KO CY, Yao CC, Li YC, Lu LS, et al
     Clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms: A single-center experience in Southern Taiwan.
     PLoS One. 2022;17:e0275723.
     PubMed     Abstract available
     
     
     
139. PARK JH, Kim MY, Choi IS, Kim JW, et al
     Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients.
     PLoS One. 2022;17:e0276497.
     PubMed     Abstract available
     
     
     
140. MOCHIZUKI K, Kudo SE, Kato K, Kudo K, et al
     Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
     PLoS One. 2022;17:e0273566.
     PubMed     Abstract available
     
     
     
141. PACHE B, Balaya V, Mathis J, Hubner M, et al
     Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
     PLoS One. 2022;17:e0276438.
     PubMed     Abstract available
     
     
     
142. WU D, Xiang L, Peng L, Gu H, et al
     Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
     PLoS One. 2022;17:e0276430.
     PubMed     Abstract available
     
     
     
143. BRUCKNER HW, Bassali F, Dusowitz E, Gurell D, et al
     Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival times.
     PLoS One. 2022;17:e0276492.
     PubMed     Abstract available
     
     
     
144. EJAZ SA, Saeed A, Birmani PR, Katubi KM, et al
     In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization.
     PLoS One. 2022;17:e0271602.
     PubMed     Abstract available
     
     
     
145. ZHANG X, Ma S, Guo Y, Luo Y, et al
     Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis of 15 trials.
     PLoS One. 2022;17:e0276599.
     PubMed     Abstract available
     
     
     
146. ANGER F, Lichthardt S, Haubitz I, Wagner J, et al
     Is there a weekend effect in emergency surgery for colorectal carcinoma? Analysis from the German StuDoQ registry.
     PLoS One. 2022;17:e0277050.
     PubMed     Abstract available
     
     
     
147. TARIQ H, Noreen Z, Ahmad A, Khan L, et al
     Colibactin possessing E. coli isolates in association with colorectal cancer and their genetic diversity among Pakistani population.
     PLoS One. 2022;17:e0262662.
     PubMed     Abstract available
     
     
     
148. MONDSCHEIN S, Subiabre F, Yankovic N, Estay C, et al
     Colorectal cancer trends in Chile: A Latin-American country with marked socioeconomic inequities.
     PLoS One. 2022;17:e0271929.
     PubMed     Abstract available
     
     
     
149. SUN Y, Li H, Ma Z, Wang J, et al
     Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer.
     PLoS One. 2022;17:e0278114.
     PubMed     Abstract available
     
     
     
150. VANACLOCHA-ESPI M, Pinto-Carbo M, Martin-Pozuelo J, Romeo-Cervera P, et al
     Construction of an individual socioeconomic status index for analysing inequalities in colorectal cancer screening.
     PLoS One. 2022;17:e0278275.
     PubMed     Abstract available
     
     
     
151. MAHDOUANI M, Ben Ahmed S, Hmila F, Rais H, et al
     Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer.
     PLoS One. 2022;17:e0278283.
     PubMed     Abstract available
     
     
     
152. WANG Q, Li Z, Guo J, Li W, et al
     Effect of Chinese herbal medicine formula on progression-free survival among patients with metastatic colorectal cancer: Study protocol for a multi-center, double-blinded, randomized, placebo-controlled trial.
     PLoS One. 2022;17:e0275058.
     PubMed     Abstract available
     
     
     
153. XIA W, Gao Z, Jiang X, Jiang L, et al
     Alzheimer's risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/beta-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer.
     PLoS One. 2022;17:e0278774.
     PubMed     Abstract available
     
     
     
154. LAL A, Gao L, Tan E, McCaffrey N, et al
     Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study.
     PLoS One. 2022;17:e0279177.
     PubMed     Abstract available
     
     
     
155. KO YS, Choi YM, Kim M, Park Y, et al
     Improving quality control in the routine practice for histopathological interpretation of gastrointestinal endoscopic biopsies using artificial intelligence.
     PLoS One. 2022;17:e0278542.
     PubMed     Abstract available
     
     
     
156. RAMANATHAN K, Schliemann D, Binti Ibrahim Tamin NS, Mohan D, et al
     Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
     PLoS One. 2022;17:e0279489.
     PubMed     Abstract available
     
     
     
157. KIM KW, Kang HW, Yoo H, Jun Y, et al
     Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.
     PLoS One. 2022;17:e0279242.
     PubMed     Abstract available
     
     
     
158. SUMAN S, Moon BH, Datta K, Kallakury BVS, et al
     Heavy-ion radiation-induced colitis and colorectal carcinogenesis in Il10-/- mice display co-activation of beta-catenin and NF-kappaB signaling.
     PLoS One. 2022;17:e0279771.
     PubMed     Abstract available
     
     
     January 2021
159. 
     Correction: Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
     PLoS One. 2021;16:e0258077.
     PubMed     Abstract available
     
     
     
160. RODRIGUEZ-TOMAS E, Arenas M, Gomez J, Acosta J, et al
     Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy.
     PLoS One. 2021;16:e0250453.
     PubMed     Abstract available
     
     
     
161. SUN Q, Pastor L, Du J, Powell MJ, et al
     A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening.
     PLoS One. 2021;16:e0244332.
     PubMed     Abstract available
     
     
     
162. O'SHEA R, Taylor N, Crook A, Jacobs C, et al
     Health system interventions to integrate genetic testing in routine oncology services: A systematic review.
     PLoS One. 2021;16:e0250379.
     PubMed     Abstract available
     
     
     
163. YAMANO T, Kubo S, Sonoda E, Kominato T, et al
     Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
     PLoS One. 2021;16:e0250072.
     PubMed     Abstract available
     
     
     
164. DUBE MANDISHORA RS, Rounge TB, Fitzpatrick M, Christiansen IK, et al
     Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
     PLoS One. 2021;16:e0250426.
     PubMed     Abstract available
     
     
     
165. EL BIZRI M, El Sheikh M, Lee GE, Sewitch MJ, et al
     Mobile health technologies supporting colonoscopy preparation: A systematic review and meta-analysis of randomized controlled trials.
     PLoS One. 2021;16:e0248679.
     PubMed     Abstract available
     
     
     
166. MORIMOTO M, Taniguchi K, Yamamoto O, Naka T, et al
     Preoperative white blood cell count predicts anastomotic leakage in patients with left-sided colorectal cancer.
     PLoS One. 2021;16:e0258713.
     PubMed     Abstract available
     
     
     
167. SHIRAKAMI Y, Nakanishi T, Ozawa N, Ideta T, et al
     Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
     PLoS One. 2021;16:e0251942.
     PubMed     Abstract available
     
     
     
168. CHEN S, Wang Y, Wang B, Zhang L, et al
     A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
     PLoS One. 2021;16:e0258741.
     PubMed     Abstract available
     
     
     
169. 
     Expression of Concern: A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
     PLoS One. 2021;16:e0259176.
     PubMed    
     
     
     
170. KOBORI T, Tameishi M, Tanaka C, Urashima Y, et al
     Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.
     PLoS One. 2021;16:e0250889.
     PubMed     Abstract available
     
     
     
171. BOWLER-BARNETT E, Martinez-Garcia FD, Sherwood M, Aleidan A, et al
     Proteomic characterization of GSK3beta knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
     PLoS One. 2021;16:e0246707.
     PubMed     Abstract available
     
     
     
172. CHEN YC, Tsai HL, Li CC, Huang CW, et al
     Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.
     PLoS One. 2021;16:e0259460.
     PubMed     Abstract available
     
     
     
173. TRUELSEN SLB, Mousavi N, Wei H, Harvey L, et al
     The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
     PLoS One. 2021;16:e0253258.
     PubMed     Abstract available
     
     
     
174. BULUT G, Guner Oytun M, Almuradova E, Harman M, et al
     Contribution of "complete response to treatment" to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis.
     PLoS One. 2021;16:e0259622.
     PubMed     Abstract available
     
     
     
175. EZENKWA US, Okolo CA, Ogun GO, Akere A, et al
     Cyclooxygenase-2 expression in colorectal carcinoma, adenomatous polyps and non-tumour bearing margins of resection tissues in a cohort of black Africans.
     PLoS One. 2021;16:e0255235.
     PubMed     Abstract available
     
     
     
176. ORABI KY, Abaza MS, Luqmani YA, Al-Attiyah R, et al
     Psiadin and plectranthone selectively inhibit colorectal carcinoma cells proliferation via modulating cyclins signaling and apoptotic pathways.
     PLoS One. 2021;16:e0252820.
     PubMed     Abstract available
     
     
     
177. TAKASU C, Yamashita S, Morine Y, Yoshikawa K, et al
     The role of the immunoescape in colorectal cancer liver metastasis.
     PLoS One. 2021;16:e0259940.
     PubMed     Abstract available
     
     
     
178. CHAIWONGKOT A, Phanuphak N, Pankam T, Bhattarakosol P, et al
     Human papillomavirus 16 L1 gene methylation as a potential biomarker for predicting anal intraepithelial neoplasia in men who have sex with men (MSM).
     PLoS One. 2021;16:e0256852.
     PubMed     Abstract available
     
     
     
179. OMIDVARI AH, Lansdorp-Vogelaar I, de Koning HJ, Meester RGS, et al
     Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
     PLoS One. 2021;16:e0253893.
     PubMed     Abstract available
     
     
     
180. KOO K, Ward R, Smith RL, Ruben J, et al
     Temporal determinants of tumour response to neoadjuvant rectal radiotherapy.
     PLoS One. 2021;16:e0254018.
     PubMed     Abstract available
     
     
     
181. SARGENTI A, Musmeci F, Cavallo C, Mazzeschi M, et al
     A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib.
     PLoS One. 2021;16:e0252907.
     PubMed     Abstract available
     
     
     
182. SOMMARIVA S, Scussolini M, Cossu V, Marini C, et al
     The role of endoplasmic reticulum in in vivo cancer FDG kinetics.
     PLoS One. 2021;16:e0252422.
     PubMed     Abstract available
     
     
     
183. WANG T, Fei J, Nie S
     Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis.
     PLoS One. 2021;16:e0260035.
     PubMed     Abstract available
     
     
     
184. SYED SOFFIAN SS, Safian N, Nawi AM, Ahmad SB, et al
     Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
     PLoS One. 2021;16:e0258129.
     PubMed     Abstract available
     
     
     
185. BENEDEK Z, Surjan C, Belicza E
     Potential considerations in decision making on laparoscopic colorectal resections in Hungary based on administrative data.
     PLoS One. 2021;16:e0257811.
     PubMed     Abstract available
     
     
     
186. PARK J, Han JS, Jo HJ, Kim HY, et al
     Resting heart rate is associated with colorectal advanced adenoma.
     PLoS One. 2021;16:e0254505.
     PubMed     Abstract available
     
     
     
187. GOLDSBURY DE, Feletto E, Weber MF, Haywood P, et al
     Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
     PLoS One. 2021;16:e0260088.
     PubMed     Abstract available
     
     
     
188. CHENG YW, Li YC
     Factors affecting the follow-up time after a positive result in the fecal occult blood test.
     PLoS One. 2021;16:e0258130.
     PubMed     Abstract available
     
     
     
189. HEIL TC, Melis RJF, Maas HAAM, van Munster BC, et al
     Technical efficiency evaluation of colorectal cancer care for older patients in Dutch hospitals.
     PLoS One. 2021;16:e0260870.
     PubMed     Abstract available
     
     
     
190. PERNE C, Peters S, Cartolano M, Horpaopan S, et al
     Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis.
     PLoS One. 2021;16:e0259185.
     PubMed     Abstract available
     
     
     
191. FIGUEIREDO JC, Passarelli MN, Wei W, Ahnen DJ, et al
     Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions.
     PLoS One. 2021;16:e0258878.
     PubMed     Abstract available
     
     
     
192. WALCHECK MT, Matkowskyj KA, Turco A, Blaine-Sauer S, et al
     Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.
     PLoS One. 2021;16:e0259245.
     PubMed     Abstract available
     
     
     
193. BREDNO J, Lipson J, Venn O, Aravanis AM, et al
     Clinical correlates of circulating cell-free DNA tumor fraction.
     PLoS One. 2021;16:e0256436.
     PubMed     Abstract available
     
     
     
194. MUNRO MJ, Peng L, Wickremesekera SK, Tan ST, et al
     Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors.
     PLoS One. 2021;16:e0256280.
     PubMed     Abstract available
     
     
     
195. LI K, Fathan MI, Patel K, Zhang T, et al
     Colonoscopy polyp detection and classification: Dataset creation and comparative evaluations.
     PLoS One. 2021;16:e0255809.
     PubMed     Abstract available
     
     
     
196. POURNOOR E, Mousavian Z, Nowzari-Dalini A, Masoudi-Nejad A, et al
     A propagation-based seed-centric local community detection for multilayer environment: The case study of colon adenocarcinoma.
     PLoS One. 2021;16:e0255718.
     PubMed     Abstract available
     
     
     
197. MOHAMMED M, Mboya IB, Mwambi H, Elbashir MK, et al
     Predictors of colorectal cancer survival using cox regression and random survival forests models based on gene expression data.
     PLoS One. 2021;16:e0261625.
     PubMed     Abstract available
     
     
     
198. DAEMEN A, Udyavar AR, Sandmann T, Li C, et al
     Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
     PLoS One. 2021;16:e0262198.
     PubMed     Abstract available
     
     
     
199. SIEGEL EM, Ajidahun A, Berglund A, Guerrero W, et al
     Genome-wide host methylation profiling of anal and cervical carcinoma.
     PLoS One. 2021;16:e0260857.
     PubMed     Abstract available
     
     
     
200. ASTARITA JL, Keerthivasan S, Husain B, Senbabaoglu Y, et al
     The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.
     PLoS One. 2021;16:e0260800.
     PubMed     Abstract available
     
     
     
201. ELZINGA J, van der Lugt B, Belzer C, Steegenga WT, et al
     Characterization of increased mucus production of HT29-MTX-E12 cells grown under Semi-Wet interface with Mechanical Stimulation.
     PLoS One. 2021;16:e0261191.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.